P

PreludeDx

34 employees

Prelude delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Life Science

Date founded

2009

Funding rounds raised

Total raised

$20M

from 1 investors over 1 rounds

P

PreludeDx raised $20M on March 22, 2022

Investors: Canepa Healthcare, LLC

FAQ